CDER Report Adds To New FDA Research Agenda

Law360, New York (July 25, 2011, 7:22 PM EDT) -- The U.S. Food and Drug Administration's Center for Drug and Evaluation Research on Monday released a draft report highlighting major areas of scientific need aimed at helping the agency craft a strategic science and research agenda.

The report, titled “Identifying CDER's Science and Research Needs,” described seven categories of concern — including the need for improved access to post-market data sources, improved clinical trials and enhanced individualization of patient treatment — most commonly cited in interviews with more than 200 CDER employees.

The draft report will...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.